Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Assets Average (2016 - 2025)

Historic Assets Average for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $7.1 million.

  • BioRestorative Therapies' Assets Average fell 5386.72% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 5386.72%. This contributed to the annual value of $12.4 million for FY2024, which is 1430.43% down from last year.
  • Per BioRestorative Therapies' latest filing, its Assets Average stood at $7.1 million for Q3 2025, which was down 5386.72% from $9.4 million recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Assets Average high stood at $21.7 million for Q1 2022, and its period low was $2.5 million during Q3 2021.
  • In the last 5 years, BioRestorative Therapies' Assets Average had a median value of $13.6 million in 2023 and averaged $12.9 million.
  • In the last 5 years, BioRestorative Therapies' Assets Average soared by 63839.1% in 2022 and then tumbled by 5386.72% in 2025.
  • BioRestorative Therapies' Assets Average (Quarter) stood at $12.3 million in 2021, then surged by 39.49% to $17.2 million in 2022, then fell by 23.12% to $13.2 million in 2023, then rose by 1.67% to $13.4 million in 2024, then crashed by 47.27% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, $9.4 million for Q2 2025, and $11.3 million during Q1 2025.